-
1.发明申请RIM elastomers based on isocyanurates of isophorone diisocyanate and prepolymers thereof 审中-公开基于异佛尔酮二异氰酸酯的异氰脲酸酯和其预聚物的RIM弹性体公开(公告)号：US20070142601A1
公开(公告)日：2007-06-21
申请号：US11300837
申请日：2005-12-15
申请人： Neil Nodelman , David Steppan , Michael Super
发明人： Neil Nodelman , David Steppan , Michael Super
IPC分类号： C08G18/00
CPC分类号： C08G18/792 , C08G18/22 , C08G18/3203 , C08G18/3225 , C08G18/3278 , C08G18/5021 , C08G18/6688
摘要： This invention relates to RIM molded elastomers prepared from aliphatic isocyanurates and prepolymers thereof. The reactive systems used to prepare these elastomers exhibit longer gel times with improved flow and can still be demolded in about 30 seconds. The resultant elastomers have good weatherability without painting. This invention also relates to phase stable polyol blends.
摘要翻译： 本发明涉及由脂族异氰脲酸酯及其预聚物制备的RIM模塑弹性体。 用于制备这些弹性体的反应体系表现出更长的凝胶时间，并具有改善的流动性，并且仍可在约30秒内脱模。 所得的弹性体在没有涂漆的情况下具有良好的耐候性。 本发明还涉及相稳定多元醇共混物。
-
公开(公告)号：US20140227723A1
公开(公告)日：2014-08-14
申请号：US14233553
申请日：2012-07-18
申请人： Donald E. Ingber , Michael Super , Jeffrey Charles Way , Mark J. Cartwright , Julia B. Berthet , Dinah R. Super , Martin M. Rottman , Alexander Watters
发明人： Donald E. Ingber , Michael Super , Jeffrey Charles Way , Mark J. Cartwright , Julia B. Berthet , Dinah R. Super , Martin M. Rottman , Alexander Watters
IPC分类号： C07K16/12 , G01N33/569 , C07K14/42
CPC分类号： C07K16/12 , A61K47/68 , A61K47/6815 , C07K14/42 , C07K2319/33 , G01N33/54353 , G01N33/56911 , G01N33/56916 , G01N33/56938 , G01N33/56961 , G01N2333/42 , G01N2333/4724 , Y02A50/53 , Y02A50/58
摘要： Described herein are engineered microbe-targeting or microbe-binding molecules, kits comprising the same and uses thereof. Some particular embodiments of the microbe-targeting or microbe-binding molecules comprise a carbohydrate recognition domain of mannose-binding lectin, or a fragment thereof, linked to a portion of a Fc region. In some embodiments, the microbe-targeting molecules or microbe-binding molecules can be conjugated to a substrate, e.g., a magnetic microbead, forming a microbe-targeting substrate (e.g., a microbe-targeting magnetic microbead). Such microbe-targeting molecules and/or substrates and the kits comprising the same can bind and/or capture of a microbe and/or microbial matter thereof, and can thus be used in various applications, e.g., diagnosis and/or treatment of an infection caused by microbes such as sepsis in a subject or any environmental surface. Microbe-targeting molecules and/or substrates can be regenerated after use by washing with a low pH buffer or buffer in which calcium is insoluble.
摘要翻译： 本文描述了工程化的微生物靶向或微生物结合分子，包含其的试剂盒及其用途。 微生物靶向或微生物结合分子的一些具体实施方案包含与Fc区的一部分连接的甘露糖结合凝集素或其片段的碳水化合物识别结构域。 在一些实施方案中，微生物靶向分子或微生物结合分子可以与基底（例如磁性微珠）缀合，形成微生物靶向底物（例如，微生物靶向磁性微珠）。 这样的微生物靶向分子和/或底物及其包含的试剂盒可以结合和/或捕获微生物和/或其微生物物质，因此可以用于各种应用中，例如诊断和/或治疗感染 由微生物引起，如受试者或任何环境表面的败血症。 微生物靶向分子和/或底物可以在使用后通过用不溶于钙的低pH缓冲液或缓冲液洗涤而再生。
-
公开(公告)号：US20130157283A1
公开(公告)日：2013-06-20
申请号：US13522800
申请日：2011-01-19
申请人： Chong Wing Yung , Donald E. Ingber , Ryan Mcomber Cooper , Frank Vollmer , Karel Domansky , Daniel Christopher Leslie , Michael Super
发明人： Chong Wing Yung , Donald E. Ingber , Ryan Mcomber Cooper , Frank Vollmer , Karel Domansky , Daniel Christopher Leslie , Michael Super
IPC分类号： C12Q1/04
CPC分类号： C12Q1/04 , B01L3/502761 , B01L2200/0668 , B01L2300/0816 , B01L2400/043 , G01N33/54306 , G01N33/54333 , G01N33/54366 , G01N35/0098
摘要： A microfluidic device of a diagnostic and detection system includes an inlet port connected by one or more microchannels to an outlet port and includes a capture and visualization chamber (CVC) connected to at least one microchannel. A fluid to be analyzed can be mixed with magnetic microbeads that have an affinity to become bound to target components, such as pathogens in the fluid. The fluid including the magnetically bound target components can be injected through the microfluidic device. Magnetic field gradient, such as provided by permanent or electro-magnets, can be applied to the fluid and the magnetically bound target components flowing through the microfluidic device to cause the magnetically bound target components to migrate into the (CVC) and become separated from the fluid. The magnetically bound target components can be analyzed and tested using various techniques to detect the presence of specific organic and inorganic materials, such as pathogens in bio-fluids and contamination in liquid food sources (e.g. water). The device and method provide a system for rapidly detecting pathogens and contamination in relatively small fluid samples.
摘要翻译： 诊断和检测系统的微流体装置包括通过一个或多个微通道连接到出口的入口端口，并且包括连接到至少一个微通道的捕获和可视化室（CVC）。 要分析的流体可以与具有亲和性的磁性微珠混合，以结合到目标组分，例如流体中的病原体。 包括磁结合的靶组分的流体可以通过微流体装置注入。 磁场梯度，例如由永磁体或电磁铁提供的磁场梯度可以被施加到流过微流体装置的流体和磁结合的目标组分，以使磁结合的靶组分迁移到（CVC）中并与 流体。 可以使用各种技术来分析和测试磁结合的靶组分，以检测特定有机和无机材料（例如生物流体中的病原体和液体食物来源（例如水））中的污染物的存在。 该装置和方法提供用于在相对小的流体样品中快速检测病原体和污染物的系统。
-
公开(公告)号：US09932484B2
公开(公告)日：2018-04-03
申请号：US13980858
申请日：2012-01-19
IPC分类号： C09D5/16 , A61L15/24 , A61L15/34 , A61L15/42 , A61L15/46 , A61L27/28 , A61L27/34 , A61L27/50 , A61L33/00 , A61L33/06 , F15D1/02 , F15D1/10 , B05D5/08
CPC分类号： C09D5/1693 , A61L15/24 , A61L15/34 , A61L15/42 , A61L15/46 , A61L27/28 , A61L27/34 , A61L27/50 , A61L33/0094 , A61L33/064 , A61L2400/12 , B05D5/083 , C09D5/1656 , C09D5/1681 , F15D1/02 , F15D1/10 , C08L27/12
摘要： A self-healing, scratch resistant slippery surface that is manufactured by wicking a chemically-inert, high-density liquid coating over a roughened solid surface featuring micro and nanoscale topographies is described. Such a slippery surface shows anti-wetting properties, as well as exhibits significant reduction of adhesion of a broad range of biological materials, including particles in suspension or solution. Specifically, the slippery surfaces can be applied to medical devices and equipment to effectively repel biological materials such as blood, and prevent, reduce, or delay coagulation and surface-mediated clot formation. Moreover, the slippery surfaces can be used to prevent fouling by microorganisms such as bacteria.
-
公开(公告)号：US09593160B2
公开(公告)日：2017-03-14
申请号：US14233553
申请日：2012-07-18
申请人： Donald E. Ingber , Michael Super , Jeffrey Charles Way , Mark J. Cartwright , Julia B. Berthet , Dinah R. Super , Martin M. Rottman , Alexander Watters
发明人： Donald E. Ingber , Michael Super , Jeffrey Charles Way , Mark J. Cartwright , Julia B. Berthet , Dinah R. Super , Martin M. Rottman , Alexander Watters
IPC分类号： C07K14/42 , C07K16/12 , A61K47/48 , G01N33/543 , G01N33/569
CPC分类号： C07K16/12 , A61K47/68 , A61K47/6815 , C07K14/42 , C07K2319/33 , G01N33/54353 , G01N33/56911 , G01N33/56916 , G01N33/56938 , G01N33/56961 , G01N2333/42 , G01N2333/4724 , Y02A50/53 , Y02A50/58
摘要： Described herein are engineered microbe-targeting or microbe-binding molecules, kits comprising the same and uses thereof. Some particular embodiments of the microbe-targeting or microbe-binding molecules comprise a carbohydrate recognition domain of mannose-binding lectin, or a fragment thereof, linked to a portion of a Fc region. In some embodiments, the microbe-targeting molecules or microbe-binding molecules can be conjugated to a substrate, e.g., a magnetic microbead, forming a microbe-targeting substrate (e.g., a microbe-targeting magnetic microbead). Such microbe-targeting molecules and/or substrates and the kits comprising the same can bind and/or capture of a microbe and/or microbial matter thereof, and can thus be used in various applications, e.g., diagnosis and/or treatment of an infection caused by microbes such as sepsis in a subject or any environmental surface. Microbe-targeting molecules and/or substrates can be regenerated after use by washing with a low pH buffer or buffer in which calcium is insoluble.
摘要翻译： 本文描述了工程化的微生物靶向或微生物结合分子，包含其的试剂盒及其用途。 微生物靶向或微生物结合分子的一些具体实施方案包括与Fc区的一部分连接的甘露糖结合凝集素或其片段的碳水化合物识别结构域。 在一些实施方案中，微生物靶向分子或微生物结合分子可以与基底（例如磁性微珠）缀合，形成微生物靶向底物（例如，微生物靶向磁性微珠）。 这样的微生物靶向分子和/或底物及其包含的试剂盒可以结合和/或捕获微生物和/或其微生物物质，因此可用于各种应用中，例如诊断和/或治疗感染 由微生物引起，如受试者或任何环境表面的败血症。 微生物靶向分子和/或底物可以在使用后通过用不溶于钙的低pH缓冲液或缓冲液洗涤而再生。
-
公开(公告)号：US08691952B2
公开(公告)日：2014-04-08
申请号：US11648505
申请日：2006-12-29
CPC分类号： C07K16/30 , A61K39/3955 , A61K2039/505 , C07K16/2803 , C07K16/2866 , C07K16/2896 , C07K2317/24 , C07K2317/41 , C07K2317/56 , C07K2317/567 , C07K2317/732 , A61K2300/00
摘要： Anti-CD19 B4 antibodies with modified variable regions are disclosed. The modified anti-CD19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a T-cell response.
摘要翻译： 公开了具有改变的可变区的抗CD19 B4抗体。 修饰的抗CD19可变区多肽具有对重链可变区或轻链可变区的一个或多个构架区或互补决定区的改变，从而降低T细胞应答。
-
公开(公告)号：US09150631B2
公开(公告)日：2015-10-06
申请号：US13574191
申请日：2011-01-19
CPC分类号： C07K14/4726 , C07K16/44 , C07K17/00 , C07K2317/53 , C07K2317/66 , C07K2319/30 , G01N33/56961 , G01N2333/40
摘要： The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.
摘要翻译： 本发明提供可用于结合生物病原体或鉴定用于治疗和诊断感染性疾病，血源性感染或败血症患者的装置和系统的亚类或特定病原体物种的工程化分子调理素。 本发明的一个方面提供了甘露糖结合凝集素（MBL），其是作为先天免疫系统的一部分的丰富的天然血清蛋白。 这种蛋白凝集素在几乎所有类型的生物病原体（病毒，细菌，真菌，原生动物）上结合表面分子的能力使MBL的工程化形式在诊断和治疗感染性疾病和败血症方面非常有用。
-
公开(公告)号：US20130035283A1
公开(公告)日：2013-02-07
申请号：US13574191
申请日：2011-01-19
CPC分类号： C07K14/4726 , C07K16/44 , C07K17/00 , C07K2317/53 , C07K2317/66 , C07K2319/30 , G01N33/56961 , G01N2333/40
摘要： The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (MBL), which is an abundant natural serum protein that is part of the innate immune system. The ability of this protein lectin to bind to surface molecules on virtually all classes of biopathogens (viruses, bacteria, fungi, protozoans) make engineered forms of MBL extremely useful in diagnosing and treating infectious diseases and sepsis.
摘要翻译： 本发明提供可用于结合生物病原体或鉴定用于治疗和诊断感染性疾病，血源性感染或败血症患者的装置和系统的亚类或特定病原体物种的工程化分子调理素。 本发明的一个方面提供了甘露糖结合凝集素（MBL），其是作为先天免疫系统的一部分的丰富的天然血清蛋白。 这种蛋白凝集素在几乎所有类型的生物病原体（病毒，细菌，真菌，原生动物）上结合表面分子的能力使MBL的工程化形式在诊断和治疗感染性疾病和败血症方面非常有用。
-
公开(公告)号：US20060073346A1
公开(公告)日：2006-04-06
申请号：US10957993
申请日：2004-10-04
申请人： Michael Super , Karl Haider
发明人： Michael Super , Karl Haider
IPC分类号： B32B27/40
CPC分类号： C08G18/672 , C08G18/7664 , Y10T428/31551
摘要： The present invention provides polyester-polyurethane composites made by applying a polyurethane matrix including at least one polyether containing both hydroxyl-functionality and unsaturation-functionality to an unsaturation-containing polyester matrix. Adhesion between the polyester matrix and the polyurethane matrix in the inventive composites is promoted by the polyether containing both hydroxyl-functionality and unsaturation-functionality.
摘要翻译： 本发明提供了通过将包含至少一种含有羟基官能团和不饱和官能团的聚醚的聚氨酯基质涂覆到含不饱和聚酯基体而制备的聚酯 - 聚氨酯复合材料。 本发明复合材料中聚酯基质和聚氨酯基质之间的粘合力由含有羟基官能团和不饱和官能团的聚醚促进。
-
公开(公告)号：US20140220617A1
公开(公告)日：2014-08-07
申请号：US14007738
申请日：2012-04-02
申请人： Chong Wing Yung , Karel Domansky , Richard Terry , David Kalish , Alexa Schulte , Joo Hun Kang , Donald E. Ingber , Michael Super , Ryan M. Cooper
发明人： Chong Wing Yung , Karel Domansky , Richard Terry , David Kalish , Alexa Schulte , Joo Hun Kang , Donald E. Ingber , Michael Super , Ryan M. Cooper
CPC分类号： C12Q1/04 , A61M1/36 , A61M1/3618 , B01L3/502715 , B01L3/50273 , B01L3/502761 , B01L3/56 , B01L2200/0652 , B01L2300/0864 , B01L2300/0867 , B01L2300/0887 , B01L2400/043 , B01L2400/0487 , B03C1/002 , B03C1/01 , B03C1/0332 , B03C1/0335 , B03C1/288 , B03C2201/26
摘要： A dialysis like therapeutic (DLT) device is provided. The DLT device includes at least one source channel connected at least one collection channels by one or more transfer channels. Fluid contacting surface of the channels can be an anti-fouling surface such as slippery liquid-infused porous surface (SLIPS). Fluids can be flown at high flow rates through the channels. The target components of the source fluid can be magnetic or bound to magnetic particles using an affinity molecule. A source fluid containing magnetically bound target components can be pumped through the source channel of the microfluidic device. A magnetic field gradient can be applied to the source fluid in the source channel causing the magnetically bound target components to migrate through the transfer channel into the collection channel. The collection channel can include a collection fluid to flush the target components out of the collection channel. The target components can be subsequently analyzed for detection and diagnosis. The source channel and the collection channels of the microfluidic device are analogous to the splenic arterioles and venules, respectively; the transfer channels mimic the vascular sinusoids of the spleen where opsonized particles are retained. Thus, the device acts as a dialysis like therapeutic device by combining fluidics and magnetics.
摘要翻译： 提供透析治疗（DLT）装置。 DLT设备包括通过一个或多个传输信道连接至少一个收集信道的至少一个源信道。 通道的流体接触表面可以是防污表面，例如滑动的液体注入的多孔表面（SLIPS）。 流体可以通过通道以高流速流动。 源流体的目标组分可以是磁性的或使用亲和分子结合到磁性颗粒。 含有磁结合的靶组分的源流体可以泵送通过微流体装置的源通道。 磁场梯度可以施加到源通道中的源流体，使得磁结合的目标分量通过传输通道迁移到收集通道中。 收集通道可以包括收集流体以将目标组分冲洗出收集通道。 随后分析目标成分进行检测和诊断。 微流体装置的源通道和收集通道分别类似于脾小动脉和小静脉; 转移通道模拟脾脏的血管窦状，其中保留调理颗粒。 因此，通过组合流体学和磁性，该装置作为透析像治疗装置。
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.032 秒)
